These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17766926)

  • 21. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD; Parlan G; Bailey AL; Yee G; Yu M; Chan JY
    Clin Ther; 2009 Jan; 31(1):74-88. PubMed ID: 19243708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond insulin replacement: addressing the additional needs of the diabetes patient.
    Dailey G
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():83-97. PubMed ID: 18577160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M; Orsini-Federici M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin glargine (Lantus) and cancer risk.
    Med Lett Drugs Ther; 2009 Aug; 51(1319):67-8. PubMed ID: 19696708
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE
    J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight matters. How new antiobesity drugs can be part of diabetes management.
    Tsai A
    Diabetes Forecast; 2015; 68(1):50-5. PubMed ID: 25647938
    [No Abstract]   [Full Text] [Related]  

  • 27. Intensive glucose control in type 2 diabetes.
    Tobey TA
    N Engl J Med; 2008 Oct; 359(14):1520; author reply 1520-1. PubMed ID: 18837145
    [No Abstract]   [Full Text] [Related]  

  • 28. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C; Hernández Herrero C; Rivas Fernández M
    Diabet Med; 2008 Aug; 25(8):916-23. PubMed ID: 18959604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Glitazones critically evaluated].
    Schernthaner G
    Dtsch Med Wochenschr; 2007 Dec; 132(49):2619. PubMed ID: 18050024
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypertension and insulin treatment in type 2 diabetes].
    Ben Salem Hachmi L; Bouguerra R; Maatki O; Smadhi H; Turki Z; Hraoui S; Ben Slama C
    Arch Mal Coeur Vaiss; 2007 Aug; 100(8):664-7. PubMed ID: 17928772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.
    Hahr AJ; Molitch ME
    Am J Ther; 2008; 15(6):543-50. PubMed ID: 19127139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weight loss in obese type 2 diabetic patients on an intensive therapeutic programme: Importance of an initial short hospitalization period.
    Saldalamacchia G; Massaro P; Pacioni D; Giordano C; Tia VN; Pellegrino S; Lilli S; Riccardi G; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):e1-2. PubMed ID: 18029160
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications.
    Tousoulis D; Tsarpalis K; Cokkinos D; Stefanadis C
    Diabetes Obes Metab; 2008 Sep; 10(10):834-42. PubMed ID: 18034844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Questions about an 80-year old patient with diabetes].
    Lars W
    Lakartidningen; 2008 May 21-27; 105(21):1593; author reply 1593. PubMed ID: 18575000
    [No Abstract]   [Full Text] [Related]  

  • 37. [Insulin-using woman with type 2 diabetes and weight problems].
    Hexeberg S; Lindberg FA
    Tidsskr Nor Laegeforen; 2008 Feb; 128(4):443-5. PubMed ID: 18309535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Achieve better glucose control for your hospitalized patients.
    Woolever DR
    J Fam Pract; 2008 Dec; 57(12):782-8. PubMed ID: 19080760
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
    Koren S; Fantus IG
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.